Related Experiment Video

Updated: Aug 15, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

[Neoadjuvant treatment of non small cell lung cancer -- contra]

M Thomas1

  • 1Internistische Onkologie der Thoraxtumoren, Thoraxklinik am Universitätsklinikum Heidelberg. Michael.Thomas@thoraxklinik-heidelberg.de

Deutsche Medizinische Wochenschrift (1946)
|September 21, 2005
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Experiment Videos

Last Updated: Aug 15, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

Articles linked to this work by shared authors, journal, and citation graph.

Psychotic depression: advances in conceptualization and treatment.

Hospital & community psychiatry·1992

The ActionAid disability programmes: experiences in early identification and early intervention.

Indian journal of pediatrics·1992

Structure and expression of a gene from Arabidopsis thaliana encoding a protein related to SNF1 protein kinase.

Gene·1992

Is acupuncture an alternative in idiopathic pain disorder?

Acta anaesthesiologica Scandinavica·1992

Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.

The Journal of clinical endocrinology and metabolism·1992

The influence of obesity on left ventricular filling and systolic function.

American heart journal·1992

Cancer Survivorship Care in Bavaria: General Practitioners' Perspectives and a Regional Capacity Analysis.

Deutsche medizinische Wochenschrift (1946)·2026

Factors influencing treatment decisions in patients with pulmonary arterial hypertension.

Deutsche medizinische Wochenschrift (1946)·2026

[Peripheral arterial catheters - step by step].

Deutsche medizinische Wochenschrift (1946)·2026

[Colorectal Cancer].

Deutsche medizinische Wochenschrift (1946)·2026

[Neuroendocrine Tumors of the Gastrointestinal Tract].

Deutsche medizinische Wochenschrift (1946)·2026

[Adenocarcinomas of the Gastroesophageal Junction and Stomach: Current Management].

Deutsche medizinische Wochenschrift (1946)·2026

Invited submission to Reproduction and Fertility for "Evolving Perspectives in Management of Menopause Transition" Series.

Reproduction & fertility·2026

Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Breaking the Lipid Bottleneck: A Mitophagy-Driven Nanoregulator Amplifies Ferroptosis for Colorectal Cancer Immunotherapy.

Small (Weinheim an der Bergstrasse, Germany)·2026

Body Composition and Physical Activity are Associated With Prediabetes in Childhood, Adolescent, and Young Adult Cancer and Hematopoietic Cell Transplantation Survivors.

Pediatric blood & cancer·2026

Real-World Determinants of Treatment Selection in Frontline Chronic Lymphocytic Leukemia: The FIRST-CLL Study.

Hematological oncology·2026

Metastasis-directed local therapy and strategic de-escalation of systemic therapy for oligometastatic esophageal squamous cell carcinoma.

Japanese journal of clinical oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us